The First Affiliated Hospital Of Zhengzhou University

This study is testing a new drug combination for people with advanced stomach cancer that has worsened after their first treatment. The trial will check if adding an experimental drug called IBI363 to standard medications is safe and can help control the cancer. It involves about…

This study aims to see if a new two-drug combination (anlotinib + benmelstobart) works better than the current standard treatment (toripalimab + chemotherapy) for people with advanced esophageal cancer that has specific gene changes. It will involve about 578 adults who have not …

This study is testing if a new combination of therapies helps stroke survivors regain movement in their paralyzed limbs. It will compare standard rehab to rehab plus magnetic brain stimulation, and rehab plus brain stimulation combined with special blood flow restriction training…

This study is testing a new two-drug combination for women whose ovarian cancer has returned and stopped responding to standard platinum-based chemotherapy. It will enroll about 30 participants to see if combining an antibody-drug conjugate (sacituzumab tirumotecan) with an exist…

This study is testing whether spraying a menthol solution into the colon during a colonoscopy can reduce painful muscle spasms. Researchers want to see if this makes the procedure more comfortable and helps doctors spot more precancerous growths. They will enroll 440 adults under…